Literature DB >> 2317160

Fate of fibrinogen in human arterial intima.

E B Smith1, G A Keen, A Grant, C Stirk.   

Abstract

Fibrinogen and fibrinogen/fibrin-related antigen (total FRA) was measured in human normal intima and different types of atherosclerotic lesions and mural thrombi. The amount showed marked variation between groups of tissue samples, but within each group there was a significant correlation between levels of total FRA and low density lipoprotein (LDL), suggesting that some common factor must influence their influx or retention. The total FRA were analyzed by gradient sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting with antisera to whole fibrinogen and fragments D and E, and fibrinopeptide A (FPA). All intimal samples (but not thrombi) contained fragment X, the first product of plasmin digestion of fibrinogen, but fragment Y was present in only half the samples, and no core-fragment E containing FPA was detected in any sample, suggesting that fibrinogenolysis is limited. By contrast, all samples contained fragment E, which was negative for FPA, so presumably derived from fibrin; they also contained fragments D-dimer and DY, which are characteristic degradation products of cross-linked fibrin. There were no differences between samples obtained during reconstructive vascular surgery and samples obtained at autopsy, so the patterns appear to represent the steady state. This implies that within the intima there is continuous formation of cross-linked fibrin and continuous fibrinolysis, both processes generating fragments that may have atherogenic properties.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317160     DOI: 10.1161/01.atv.10.2.263

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  16 in total

1.  [Cardiovascular risk factors in diabetic nephropathy].

Authors:  J Zimmermann; L Schramm; E Mulzer; E Heidbreder; H A Henrich; C Wanner
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 2.  Fibrinogen/fibrin in atherogenesis.

Authors:  E B Smith; W D Thompson; L Crosbie; C M Stirk
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 3.  Novel aspects of fibrin(ogen) fragments during inflammation.

Authors:  Carla Jennewein; Nguyen Tran; Patrick Paulus; Peter Ellinghaus; Johannes Andreas Eble; Kai Zacharowski
Journal:  Mol Med       Date:  2011-01-04       Impact factor: 6.354

4.  Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?

Authors:  Daniel Preckel; Roland von Känel
Journal:  Heartdrug       Date:  2004

5.  Elevated Levels of Serum Fibrin and Fibrinogen Degradation Products Are Independent Predictors of Larger Coronary Plaques and Greater Plaque Necrotic Core.

Authors:  Michel T Corban; Olivia Y Hung; Girum Mekonnen; Parham Eshtehardi; Danny J Eapen; Emad Rasoul-Arzrumly; Hatem Al Kassem; Pankaj Manocha; Yi-An Ko; Laurence S Sperling; Arshed A Quyyumi; Habib Samady
Journal:  Circ J       Date:  2016-02-25       Impact factor: 2.993

Review 6.  Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris.

Authors:  F C Schoebel; T W Jax; Y Fischer; B E Strauer; M Leschke
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

7.  Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

Authors:  J D Marmur; M Rossikhina; A Guha; B Fyfe; V Friedrich; M Mendlowitz; Y Nemerson; M B Taubman
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage.

Authors:  V Sudhahar; S Ashok Kumar; P Varalakshmi; V Sujatha
Journal:  Mol Cell Biochem       Date:  2008-06-19       Impact factor: 3.396

9.  Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients.

Authors:  Abu Shamsuzzaman; Raouf S Amin; Andrew D Calvin; Diane Davison; Virend K Somers
Journal:  Sleep Breath       Date:  2014-02-09       Impact factor: 2.816

10.  D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy.

Authors:  Wouter J Kikkert; Bimmer E Claessen; Gregg W Stone; Roxana Mehran; Bernhard Witzenbichler; Bruce R Brodie; Jochen Wöhrle; Adam Witkowski; Giulio Guagliumi; Krzysztof Zmudka; José P S Henriques; Jan G P Tijssen; Elias A Sanidas; Vasiliki Chantziara; Ke Xu; George D Dangas
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.